Levamisole - Ace Pharmaceuticals

Drug Profile

Levamisole - Ace Pharmaceuticals

Alternative Names: ELMISOL; Levamisole hydrochloride

Latest Information Update: 08 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ace Pharmaceuticals
  • Class Anthelmintics; Antineoplastics; Antirheumatics; Imidazoles; Thiazoles; Urologics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Nephrotic syndrome
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Submission Withdrawal Nephrotic syndrome

Most Recent Events

  • 08 Aug 2017 Chemical structure information added
  • 11 Jul 2017 Discontinued - Phase-III for Nephrotic syndrome (In adolescents, In children, In infants) in India (PO) before July 2017
  • 23 Jun 2017 ELMISOL is available as on a Named patient basis in Netherlands before June 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top